Menu
Recruiting NCT07279571

GYN-AIDE: Gynecologic Oncology Navigation Through AI-Driven Education

— Observational Gynecologic Disease

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Non-Interventional Study.
Who it may be relevant to
Registry conditions: Gynecologic Disease. Basic parameters: from 18 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

This study seeks to understand how endometrial cancer patients get medical information about cancer care and their satisfaction with those health-seeking methods. It also assesses patient interest in using an artificial intelligence educational resource.

Detailed description

AIM 1: Evaluate use of an AI chatbot for HPV vaccine counseling:

PRIMARY OBJECTIVE:

I. To determine patient satisfaction with using an AI chatbot for HPV vaccine counseling.

SECONDARY OBJECTIVE:

I. To understand how patients currently obtain information about cancer care, vaccines, and artificial intelligence.

II. To describe patient experience with the AI-chatbot for vaccine counseling.

AIM 2: Increase rates of HPV vaccine uptake:

PRIMARY OBJECTIVE:

I. To evaluate if implementation of an AI chatbot for HPV vaccine counseling can affect the HPV vaccination rate of new patients served in the gynecologic oncology clinic.

OUTLINE: This is an observational study.

Patients complete a survey on study.

Interventions

  • Other Non-Interventional Study
    Non-interventional study

Primary outcome measures

  • Patient Satisfaction Scores [Time frame: Up to 1 year]
  • HPV Vaccination Rate [Time frame: Up to 1 year]
Secondary outcome measures (1)
  • Demographics of patients [Time frame: Up to 1 year]

Eligibility criteria

AI-chatbot Evaluation (Aim 1):

Inclusion criteria

  • Patient of the LA General gynecologic oncology clinic
  • Age 18 years or older
  • Previously obtained the HPV vaccination (initial chatbot evaluation)
  • Eligible for HPV vaccination (pilot intervention; age <46)
  • Willing and able to provide informed consent

Exclusion criteria

  • Patients who do not speak English or Spanish
  • Patients who do not provide informed consent

HPV vaccination rate (Aim 2):

Inclusion criteria

  • Patient of the LA General gynecologic oncology clinic
  • Age 18 years or older
  • Obtained the HPV vaccine

Exclusion criteria

  • None

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

United States · 1 center
  • Los Angeles General Medical Center — Los Angeles

Identifiers

NCT: NCT07279571 · 5U-25-1 · NCI-2025-03594 · UP-25-00331 · 5U-25-1 · P30CA014089

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗